Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.
about
Nephrotoxic effects of common and emerging drugs of abuse.3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress DisorderEffect of MDMA-Induced Axotomy on the Dorsal Raphe Forebrain Tract in Rats: An In Vivo Manganese-Enhanced Magnetic Resonance Imaging StudyHow MDMA's pharmacology and pharmacokinetics drive desired effects and harms.Impact of Cytochrome P450 2D6 Function on the Chiral Blood Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine (MDMA) and Its Phase I and II Metabolites in Humans.CYP2D6 function moderates the pharmacokinetics and pharmacodynamics of 3,4-methylene-dioxymethamphetamine in a controlled study in healthy individualsCarvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation.3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner.The prognosis following amphetamine poisoning.
P2860
Q21558458-78687DDB-EE7C-4C61-8A71-175467F3AF82Q22299243-48B0665A-1AF3-419D-A451-2C8075C6BB65Q28548147-945B44E6-BB22-4321-95A3-D59D8DF33D7FQ30357945-7E99AAF1-816E-419D-BD39-B48BFB117471Q35953819-C2955ED2-D9B3-4C26-AE57-295063567081Q37104121-6FCD201E-5064-4B51-9EC3-DF20E1E90495Q37337904-DE2E5610-5CF4-47DF-BE80-2D04C84A4D85Q38829190-3CCAE18B-7057-465E-A082-D60A8141D741Q40076832-86B638CD-5DEC-414C-9CB7-0EF88BC57A08
P2860
Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacokinetics and pharmacod ...... ms and drug-drug interactions.
@en
type
label
Pharmacokinetics and pharmacod ...... ms and drug-drug interactions.
@en
prefLabel
Pharmacokinetics and pharmacod ...... ms and drug-drug interactions.
@en
P2860
P1476
Pharmacokinetics and pharmacod ...... sms and drug-drug interactions
@en
P2093
Jan Meulenbelt
Saskia J Rietjens
P2860
P304
P356
10.3109/10408444.2012.725029
P407
P577
2012-10-03T00:00:00Z